Key strengths include a resilient and recently improving earnings and cash flow profile, a growing asset base, and a return to positive equity after years of deficits. The firm’s franchise in alternatives is supported by long‑tenured, sticky client relationships, a flexible and scalable platform, and differentiated capabilities in customized, impact, and emerging‑manager strategies. Strong free cash flow and rising cash balances provide financial flexibility, while ongoing technology and product initiatives position the business to operate more efficiently and tap new growth channels.

Major risks center on volatility and complexity. Earnings, margins, and cash flows have swung widely, reflecting exposure to market cycles, performance fees, and cost variability. The balance sheet still carries meaningful leverage and a history of negative retained earnings, and some reported metrics (especially on SG&A and current assets) look anomalous, indicating either data issues or unusual accounting that requires deeper review. Competitively, the firm faces fee pressure, intense rivalry in alternatives, and execution risk as it expands further into private markets and the individual investor channel.

The overall trajectory appears cautiously positive: profitability and cash generation have recovered strongly from the 2023 setback, liquidity in terms of cash has improved, and the strategic focus on higher‑growth alternative segments and new distribution channels aligns with secular industry trends. However, the business remains cyclical and somewhat unpredictable, and its leverage and data inconsistencies mean that sustained, disciplined execution will be critical for converting recent momentum into durable, less volatile performance over time.